ConductScience.org, home

Paper92180

Viral xenogenization of intact tumor cells.

Kobayashi H. Adv Cancer Res, 1979. Cited by 50 papers, by iCite.

Cite this record

ConductScience Library. Viral xenogenization of intact tumor cells. Papers, record 92180. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/92180

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Viral xenogenization of intact tumor cells.
PubMed
Journal
Adv Cancer Res
PubMed
Year
1979
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
50
iCite
Relative citation ratio, by iCite
1.27
iCite
Revised in PubMed
2019-10-27
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kobayashi HH

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibodies, NeoplasmMajor topic
Antigens, NeoplasmMajor topic
Antigens, ViralMajor topic
Neoplasms, ExperimentalMajor topic
Animals
Antibodies, Viral
Epitopes
Immunity
Immunotherapy
Mice
Rats
Virus Diseases

Source PubMed

Download CSV of topics

Cited by24

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 50 citations.

PMIDTitleJournalYearIn PapersSource
36366533Life after Cleavage: The Story of a β-Retroviral (MMTV) Signal Peptide-From Murine Lymphoma to Human Breast Cancer.Viruses2022https://conductscience.org/library/papers/36366533PubMed
34209981Combinatorial Approaches for Cancer Treatment Using Oncolytic Viruses: Projecting the Perspectives through Clinical Trials Outcomes.Viruses2021https://conductscience.org/library/papers/34209981PubMed
34209584Viral Control of Glioblastoma.Viruses2021https://conductscience.org/library/papers/34209584PubMed
33967605Advances in the Study of Antitumour Immunotherapy for Newcastle Disease Virus.Int J Med Sci2021https://conductscience.org/library/papers/33967605PubMed
32937446Xenogenization of tumor cells by fusogenic exosomes in tumor microenvironment ignites and propagates antitumor immunity.Sci Adv2020https://conductscience.org/library/papers/32937446PubMed
30767816Viral oncolytic immunotherapy in the war on cancer: Infection control considerations.Infect Control Hosp Epidemiol2019https://conductscience.org/library/papers/30767816PubMed
28536382Fifty Years of Clinical Application of Newcastle Disease Virus: Time to Celebrate!Biomedicines2016https://conductscience.org/library/papers/28536382PubMed
10341877Human tumor cell modification by virus infection: an efficient and safe way to produce cancer vaccine with pleiotropic immune stimulatory properties when using Newcastle disease virus.Gene Ther1999https://conductscience.org/library/papers/10341877PubMed
8294213Progression of a weakly tumorigenic mouse fibrosarcoma at the site of early phase of inflammation caused by plastic plates.Jpn J Cancer Res1993https://conductscience.org/library/papers/8294213PubMed
7642685Biotherapy of cancer. Perspectives of immunotherapy and gene therapy.J Cancer Res Clin Oncol1995https://conductscience.org/library/papers/7642685PubMed
6985248Antigenic variation in cancer metastasis: immune escape versus immune control.Cancer Metastasis Rev1982https://conductscience.org/library/papers/6985248PubMed
6607104Immune responses of DBA/2 mice bearing melanoma tumors: cell-mediated immune responses after challenge with vaccinia virus.Cancer Immunol Immunother1983https://conductscience.org/library/papers/6607104PubMed
6602203Protection against two spontaneous mouse leukemias conferred by immunogenic variants obtained by mutagenesis.J Exp Med1983https://conductscience.org/library/papers/6602203PubMed
6561067Immunogenic changes of murine lymphoma cells following in vitro treatment with aryl-triazene derivatives.Cancer Immunol Immunother1984https://conductscience.org/library/papers/6561067PubMed
6299231
Susceptibility of Marek's disease lymphoblastoid cell lines to infection with influenza and pseudorabies viruses and the protective effect of immunization with influenza virus-infected lymphoblastoid cells.
Arch Virol1982https://conductscience.org/library/papers/6299231PubMed
6203637Immune recognition of tumor cells in mice infected with Pichinde virus.Cancer Immunol Immunother1984https://conductscience.org/library/papers/6203637PubMed
3632916Development of highly immunogenic variants of a rat fibrosarcoma line during in vitro cultivation.Cancer Immunol Immunother1986https://conductscience.org/library/papers/3632916PubMed
3594972Prevention of metastatic spread by postoperative immunotherapy with virally modified autologous tumor cells. II. Establishment of specific systemic anti-tumor immunity.Clin Exp Metastasis1987https://conductscience.org/library/papers/3594972PubMed
3359458Characteristics of reovirus-mediated chemoimmunotherapy of murine L1210 leukemia.Cancer Immunol Immunother1988https://conductscience.org/library/papers/3359458PubMed
3297373Chemical xenogenization of experimental tumors.Cancer Metastasis Rev1987https://conductscience.org/library/papers/3297373PubMed

See all 24 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/92180

GET https://conductscience.org/api/papers/v1/92180/cited_by?page=2